Human Papillomavirus Vaccine Uptake in Males: UAE & MENA Region
HPV in MENA: Addressing low Vaccine Uptake and Rising Infection Rates
Table of Contents
Published November 6, 2025
The Growing Concern of HPV in the Middle East and North Africa
Human papillomavirus (HPV) infection represents a notable and increasing public health challenge across the Middle East and North Africa (MENA) region, impacting males as well as females. While traditionally viewed as a female health concern,HPV is increasingly recognized as a cause of several cancers in men,including anal,penile,and oropharyngeal cancers. Understanding the prevalence and addressing barriers to prevention are crucial.
Prevalence and Regional Variations
Studies indicate a substantial prevalence of HPV among men in the United Arab Emirates (UAE) and other MENA countries. The specific HPV types and infection rates vary across the region,influenced by factors like cultural practices,sexual behaviors,and access to healthcare. Limited data availability remains a key obstacle to accurately assessing the true burden of disease.
Barriers to HPV Vaccination in males
Despite the availability of safe and effective HPV vaccines, uptake among males in the MENA region remains remarkably low. Several interconnected factors contribute to this hesitancy. These include a lack of awareness about the risks of HPV-related cancers in men, misconceptions about vaccine safety, and cultural or religious beliefs. Furthermore, the absence of widespread, national immunization programs targeting males is a major impediment.
Specific barriers identified include:
- Limited Awareness: Many men are unaware that HPV can cause cancers affecting them.
- Stigma: Discussions about sexual health and HPV are frequently enough taboo, hindering open communication.
- Cost and Access: Vaccine costs can be prohibitive, and access to healthcare services may be limited in certain areas.
- Lack of Recommendation: Healthcare providers may not routinely recommend HPV vaccination for males.
the Importance of Male HPV Vaccination
Vaccinating males against HPV offers several key benefits. It provides direct protection against HPV-related cancers, reduces the overall burden of HPV infection in the population (through herd immunity), and contributes to gender equity in cancer prevention. Expanding vaccination programs to include males is a critical step towards extensive HPV control.
Strategies for Improving Vaccine Uptake
Effective strategies to increase HPV vaccine uptake among males in the MENA region require a multi-faceted approach. These include:
- Public Health Campaigns: Raising awareness about HPV and the benefits of vaccination through targeted public health campaigns.
- Healthcare Provider Education: Educating healthcare professionals about the importance of recommending HPV vaccination to male patients.
- School-Based Immunization Programs: Implementing school-based vaccination programs to reach adolescent males.
- Addressing Misconceptions: Actively addressing and debunking myths and misconceptions about HPV and the vaccine.
- Policy Changes: Advocating for the inclusion of male HPV vaccination in national immunization schedules.
